H.R. 3991 · 115th Congress
Expanded Access to Opioid Abuse Treatment Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
Lujan GrishamSponsor1 cosponsor · 1 D
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill amends the Controlled Substances Act to allow a pharmacist who meets specified criteria to be a qualifying practitioner who may administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.
What it does: CRS summary · Introduced in House · Oct 6, 2017
Expanded Access to Opioid Abuse Treatment Act of 2017
This bill amends the Controlled Substances Act to allow a pharmacist who meets specified criteria to be a qualifying practitioner who may administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Expanded Access to Opioid Abuse Treatment Act of 2017
Latest action (Oct 16, 2017): Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Policy area: Crime and Law Enforcement · Origin: House · Introduced: Oct 6, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.